Why the study?
Does admission neutrophil-lymphocyte ratio predict troponin elevation in patients presenting to the emergency department with acute chest pain?
Observational (n=244)
Does admission neutrophil-lymphocyte ratio predict troponin elevation in patients presenting to the emergency department with acute chest pain?
Answers are grounded in this paper and cite their sources.
Admission neutrophil-lymphocyte ratio may serve as an early, accessible diagnostic marker to predict subsequent troponin elevation in patients presenting with acute chest pain.
There is little data regarding the diagnostic ability of neutrophil-lymphocyte ratio (NLR) in acute coronary syndrome. Therefore, we aimed to assess the predictive value of NLR in the discrimination of troponin-positive patients. We enrolled 244 patients (mean age 61.3 ± 11.7 years, 70.5% male) who presented to the emergency service with acute chest pain. Patients were divided into 2 groups based upon the troponin positivity in the 12- to 24-hour follow-up. The admission NLR was significantly higher in the troponin-positive group (5.49 ± 4.01 vs 2.40 ± 1.36, P < .001). A cutoff point of 2.80 for NLR measured on admission had 79% sensitivity and 73% specificity in predicting follow-up troponin positivity. After multivariate analysis, admission NLR and glucose levels remained significant predictors of follow-up troponin positivity. In conclusion, NLR may be an early diagnostic marker in emergency service for discriminating patients who will have a positive troponin test in the follow-up.
No takes yet. Share an insight, caveat, or question.
Korkmaz et al. (2014) conducted an observational in Acute chest pain (n=244). Neutrophil-lymphocyte ratio (NLR) was evaluated on Troponin positivity in the 12- to 24-hour follow-up (p=< .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: